Experimental Drug & COVID-19 Pneumonia Request More Information Trial Objective Researchers want to know if an experimental drug is safe and beneficial for hospitalized patients that are being treated for COVID-19 Pneumonia. The one-time drug administration will be added into the standard COVID-19 care provided by hospitals. Enrollment Active Clinical Trials Currently Recruiting Who Can Participate Adults 18 -years-old and older who are currently admitted to Rose Medical Center in Denver, CO. with the diagnosis of COVID-19 pneumonia. Age: 18+ Gender: Any Gender Estimated Time Commitment Up to 18 weeks Includes the time a person spends in the hospital, as well as follow-up visits after hospital discharge. × Payments are intended to compensate the participant for their time and effort during the study. Payments are typically given to the participant at the end of each completed study visit. Reimbursements are intended to compensate the participant for travel-related expenses. They must be approved by the study staff and require you to turn in receipts. Travel reimbursement will vary from study to study. Payment & Reimbursement Payment: Not Provided Travel Reimbursement: Not Available Trial Contact For more information, contact: Melissa Schwab 303.398.1220 Carmen Egidio 303.398.1708 Request More Information Trial Location National Jewish Health, Rose Medical Center Trial Sponsors Pharmaceutical Company Principal Investigators Elaine Schwartz, MD, FCCP + × Elaine Schwartz, MD, FCCP Professor Medical Director, National Jewish Critical Care Service at Rose Medical Center Department of Medicine Division of Pulmonary, Critical Care & Sleep Medicine Section of Critical Care Medicine View Full Profile Patient Rating 4.8 out of 5 stars Make an Appoinment Co-Investigators William Janssen, MD + × William Janssen, MD Section Head, Critical Care Medicine Professor of Medicine Section of Critical Care Medicine Division of Pulmonary, Critical Care & Sleep Medicine Department of Medicine View Full Profile Make an Appoinment Request More Information Complete this form to learn more about this study and see if you qualify. First Name:* Last Name:* Email Address:* Phone:*
Trial Objective Researchers want to know if an experimental drug is safe and beneficial for hospitalized patients that are being treated for COVID-19 Pneumonia. The one-time drug administration will be added into the standard COVID-19 care provided by hospitals.